UY32074A - Compuestos de pirrol - Google Patents

Compuestos de pirrol

Info

Publication number
UY32074A
UY32074A UY0001032074A UY32074A UY32074A UY 32074 A UY32074 A UY 32074A UY 0001032074 A UY0001032074 A UY 0001032074A UY 32074 A UY32074 A UY 32074A UY 32074 A UY32074 A UY 32074A
Authority
UY
Uruguay
Prior art keywords
pirrol
compounds
pirrol compounds
substituent
formula
Prior art date
Application number
UY0001032074A
Other languages
English (en)
Inventor
Nishida Haruyuki
Arikawa Yasuyoshi
Fujimori Ikuo
Original Assignee
Takeda Pharmaceutical
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41508823&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY32074(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Takeda Pharmaceutical filed Critical Takeda Pharmaceutical
Publication of UY32074A publication Critical patent/UY32074A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/444—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring heteroatom, e.g. amrinone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a un compuesto representado por la fórmula: en donde A es grupo piridilo que tiene al menos un sustituyente.
UY0001032074A 2008-08-27 2009-08-26 Compuestos de pirrol UY32074A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2008218851 2008-08-27
JP2008269099 2008-10-17

Publications (1)

Publication Number Publication Date
UY32074A true UY32074A (es) 2010-03-26

Family

ID=41508823

Family Applications (1)

Application Number Title Priority Date Filing Date
UY0001032074A UY32074A (es) 2008-08-27 2009-08-26 Compuestos de pirrol

Country Status (39)

Country Link
US (3) US8969387B2 (es)
EP (1) EP2318390B1 (es)
JP (1) JP5638515B2 (es)
KR (1) KR101629181B1 (es)
CN (1) CN102197033B (es)
AR (1) AR073136A1 (es)
AU (1) AU2009284867B2 (es)
BR (1) BRPI0917705A2 (es)
CA (1) CA2735162C (es)
CL (1) CL2011000402A1 (es)
CO (1) CO6321166A2 (es)
CR (1) CR20110169A (es)
CY (1) CY1114452T1 (es)
DK (1) DK2318390T3 (es)
DO (1) DOP2011000061A (es)
EA (1) EA019741B1 (es)
EC (1) ECSP11010912A (es)
ES (1) ES2423289T3 (es)
GE (1) GEP20135786B (es)
HK (1) HK1157756A1 (es)
HR (1) HRP20130653T1 (es)
IL (1) IL211335A (es)
JO (1) JO2871B1 (es)
MA (1) MA32647B1 (es)
ME (1) ME01598B (es)
MX (1) MX2011001955A (es)
MY (1) MY152008A (es)
NZ (1) NZ591793A (es)
PE (2) PE20141174A1 (es)
PL (1) PL2318390T3 (es)
PT (1) PT2318390E (es)
RS (1) RS52872B (es)
SI (1) SI2318390T1 (es)
SM (1) SMT201300085B (es)
TW (1) TWI473798B (es)
UA (1) UA105185C2 (es)
UY (1) UY32074A (es)
WO (1) WO2010024451A1 (es)
ZA (1) ZA201101774B (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2318390B1 (en) * 2008-08-27 2013-05-01 Takeda Pharmaceutical Company Limited Pyrrole compounds
US20110229879A1 (en) * 2010-03-19 2011-09-22 University Of Rochester Methods and compositions for nuclear staining
CN102452979B (zh) * 2010-11-03 2015-04-01 天津药明康德新药开发有限公司 5-氟-3-吡啶磺酰氯的合成方法
CN102863371B (zh) * 2011-07-06 2016-04-13 中国科学院上海有机化学研究所 氟代二氢吡咯或氟代吡咯
US10039813B2 (en) 2012-02-07 2018-08-07 Massachusetts Institute Of Technology Use of antagonists of ghrelin or ghrelin receptor to prevent or treat stress-sensitive psychiatric illness
NZ703528A (en) 2012-06-27 2016-08-26 Takeda Pharmaceutical Liquid preparations of amines and organic acids stabilized by salts
MY176887A (en) 2013-02-28 2020-08-25 Takeda Pharmaceuticals Co Method for producing sulfonyl chloride compound
US9724396B2 (en) 2013-03-15 2017-08-08 Massachusetts Institute Of Technology Use of antagonists of growth hormone or growth hormone receptor to prevent or treat stress-sensitive psychiatric illness
KR102084185B1 (ko) 2013-08-29 2020-03-04 주식회사 대웅제약 테트라히드로사이클로펜타피롤 유도체 및 이의 제조방법
CN105367550A (zh) * 2014-08-11 2016-03-02 江苏柯菲平医药股份有限公司 四氢环戊二烯并[c]吡咯类衍生物、其制备方法及其在医药上的应用
UY36547A (es) 2015-02-05 2016-06-01 Bayer Cropscience Ag Derivados heterocíclicos condensados bicíclicos sustituidos por 2-(het)arilo como pesticidas
WO2016138099A1 (en) 2015-02-24 2016-09-01 Massachusetts Institute Of Technology Use of ghrelin or functional ghrelin receptor agonists to prevent and treat stress-sensitive psychiatric illness
TWI710379B (zh) 2015-07-30 2020-11-21 日商武田藥品工業股份有限公司 錠劑
AU2016307233B2 (en) 2015-08-07 2020-12-24 Bayer Cropscience Aktiengesellschaft 2-(het)aryl-substituted condensed heterocyclic derivatives as pest control agents
CN106430006B (zh) * 2016-08-18 2018-06-12 国网湖南省电力公司带电作业中心 配电线路移动式绝缘登高作业装置及方法
CN108203430A (zh) * 2016-12-16 2018-06-26 天地人和生物科技有限公司 一种新型可逆性质子泵抑制剂及其制备方法和用途
WO2019013310A1 (en) 2017-07-10 2019-01-17 Takeda Pharmaceutical Company Limited PREPARATION COMPRISING VONOPRAZAN
CN113527536B (zh) * 2020-04-21 2024-03-22 杭州德柯医疗科技有限公司 一种含氟多糖高分子化合物及其制备方法
CN115884968B (zh) * 2020-06-17 2024-06-21 日东制药株式会社 新型酸分泌抑制剂及其用途
EP4074317A1 (en) 2021-04-14 2022-10-19 Bayer AG Phosphorus derivatives as novel sos1 inhibitors
CN113620930B (zh) * 2021-07-12 2022-08-16 南京烁慧医药科技有限公司 一种含磺酰胺结构的化合物及其制备方法和应用、一种药物组合物及应用
CN118401510A (zh) * 2021-12-15 2024-07-26 日东制药株式会社 1-磺酰基吡咯衍生物的新颖盐类、其制备方法及包含其的药物组合物
WO2023113474A1 (ko) * 2021-12-15 2023-06-22 일동제약(주) 1-설포닐 피롤 유도체의 신규 염, 이의 제조 방법 및 이를 포함하는 약학 조성물
KR20230102353A (ko) * 2021-12-30 2023-07-07 주식회사 대웅제약 삼중음성유방암의 예방 또는 치료용 약학적 조성물

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE66477T1 (de) 1986-08-29 1991-09-15 Pfizer 2-guanidino-4-aryl-thiazole fuer die behandlung von peptischen geschwueren.
US5128366A (en) 1990-07-05 1992-07-07 Shinogi & Co., Ltd. Pyrrole derivatives
US5331006A (en) * 1990-08-31 1994-07-19 Warner-Lambert Company Amino acid analogs as CCK antagonists
AU8653891A (en) 1990-08-31 1992-03-30 Warner-Lambert Company Amino acid analogs as cck antagonists
CA2119155C (en) 1991-10-18 1999-06-15 Dennis Paul Phillion Fungicides for the control of take-all disease of plants
CN1071924A (zh) 1991-10-29 1993-05-12 纳幕尔杜邦公司 除草的三唑羧酸酰胺
JPH06135961A (ja) 1992-10-23 1994-05-17 Nippon Iyakuhin Kogyo Kk 新規ジフェニルピロリルフラン誘導体
US5286742A (en) * 1992-11-03 1994-02-15 American Cyanamid Company Pyrrole thiocarboxamide insecticidal and acaricidal agents
US5480902A (en) * 1993-08-31 1996-01-02 American Cyanamid Company Thienylpyrrole fungicidal agents
JPH08119936A (ja) 1994-10-18 1996-05-14 Fujisawa Pharmaceut Co Ltd 複素環式誘導体
JPH0930967A (ja) 1995-07-17 1997-02-04 Chugai Pharmaceut Co Ltd 抗潰瘍剤
ATE226193T1 (de) 1996-08-28 2002-11-15 Procter & Gamble Substituierte zyklische amine als metalloproteaseinhibitoren
HUP0000735A3 (en) 1996-12-23 2002-03-28 Bristol Myers Squibb Pharma Co Nitrogen containing heteroaromatics as factor xa inhibitors
JPH11209344A (ja) 1998-01-26 1999-08-03 Kyowa Hakko Kogyo Co Ltd 含窒素複素環化合物
GB9817548D0 (en) * 1998-08-12 1998-10-07 Novartis Ag Organic compounds
AU2825000A (en) 1999-03-10 2000-09-28 Shionogi & Co., Ltd. Medicinal compositions with (2.2.1) and (3.1.1) bicycloskeleton antagonistic to both of pgd2/txa2 receptors
TW575561B (en) 1999-03-25 2004-02-11 Hoffmann La Roche 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives
AU3783100A (en) 1999-06-14 2000-12-21 Dow Agrosciences Llc Substituted triazoles, imidazoles and pyrazoles as herbicides
ES2250196T3 (es) 1999-08-26 2006-04-16 Aventis Pharmaceuticals Inc. Aminoiminometil o aminometil dihidrobenzofuranos y benzopiranos sustituidos.
EP1284260A4 (en) 2000-05-22 2004-03-31 Takeda Chemical Industries Ltd TYROSINE PHOSPHATASE INHIBITORS
US6589978B2 (en) 2000-06-30 2003-07-08 Hoffman-La Roche Inc. 1-sulfonyl pyrrolidine derivatives
GB0016453D0 (en) 2000-07-04 2000-08-23 Hoffmann La Roche Pyrrole derivatives
EP1432693A2 (en) 2001-10-01 2004-06-30 Taisho Pharmaceutical Co. Ltd. Mch receptor antagonists
EP1442041A1 (en) 2001-11-08 2004-08-04 PHARMACIA & UPJOHN COMPANY Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
AU2002342909A1 (en) 2001-11-22 2003-06-10 Ciba Specialty Chemicals Holding Inc. Pyrrole synthesis
US20050101657A1 (en) 2001-12-28 2005-05-12 Takeda Chemical Industries Ltd. Androgen receptor antagonists
WO2003068738A1 (en) 2002-02-11 2003-08-21 Neurocrine Biosciences, Inc. Pyrrole derivatives as ligands of melanocortin receptors
AU2003209114A1 (en) * 2002-02-14 2003-09-04 Wyeth Pyrrolylalkylidene-hydrazinecarboximidamide derivatives as 5-hydroxytryptamine-6 ligands
TW200306191A (en) 2002-02-22 2003-11-16 Teijin Ltd Pyrrolopyrimidine derivatives
EP1511733A2 (en) 2002-06-13 2005-03-09 E.I. Du Pont De Nemours And Company Pyrazole and pyrrole carboxamide insecticides
US7186716B2 (en) 2002-08-12 2007-03-06 Sugen, Inc. 3-Pyrrol-pyridopyrazoles and 3-pyrrolyl-indazoles as novel kinase inhibitors
JP2004315511A (ja) 2003-03-31 2004-11-11 Taisho Pharmaceut Co Ltd Ｍｃｈ受容体アンタゴニスト
EP1628957B1 (en) 2003-05-26 2010-09-29 Takeda Pharmaceutical Company Limited Sulfopyrroles
ES2402362T3 (es) * 2004-09-30 2013-05-03 Takeda Pharmaceutical Company Limited Inhibidores de la bomba de protones
EP1655284A1 (en) 2004-10-26 2006-05-10 Aponetics AG 2-Phenylsulfopyrroles
PE20070540A1 (es) 2005-08-30 2007-06-26 Takeda Pharmaceutical Derivados de pirrol como inhibidores de la secrecion acida
US8512761B2 (en) * 2006-01-27 2013-08-20 Yale University Fast acting inhibitor of gastric acid secretion
US7994205B2 (en) * 2006-03-31 2011-08-09 Takeda Pharmaceutical Company Limited Aryl-or heteroaryl-sulfonyl compounds as acid secretion inhibitors
US8933105B2 (en) 2007-02-28 2015-01-13 Takeda Pharmaceutical Company Limited Pyrrole compounds
US20090156642A1 (en) 2007-09-28 2009-06-18 Takeda Pharmaceutical Company Limited 5-Membered heterocyclic compound
US20090318429A1 (en) 2008-04-28 2009-12-24 Institute For Oneworld Health Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
UY31830A (es) 2008-05-16 2010-01-05 Takeda Pharmaceutical Activadores de glucoquinasa
EP2318390B1 (en) 2008-08-27 2013-05-01 Takeda Pharmaceutical Company Limited Pyrrole compounds

Also Published As

Publication number Publication date
KR20110071067A (ko) 2011-06-28
MX2011001955A (es) 2011-03-29
MA32647B1 (fr) 2011-09-01
UA105185C2 (uk) 2014-04-25
JP2012501296A (ja) 2012-01-19
NZ591793A (en) 2012-11-30
US8993598B2 (en) 2015-03-31
ZA201101774B (en) 2012-06-27
SI2318390T1 (sl) 2013-08-30
CA2735162C (en) 2015-06-23
US20100056577A1 (en) 2010-03-04
CA2735162A1 (en) 2010-03-04
ME01598B (me) 2014-09-20
CL2011000402A1 (es) 2011-07-29
IL211335A0 (en) 2011-04-28
IL211335A (en) 2013-12-31
CN102197033B (zh) 2014-07-16
EA019741B1 (ru) 2014-05-30
JP5638515B2 (ja) 2014-12-10
ES2423289T3 (es) 2013-09-19
AR073136A1 (es) 2010-10-13
TWI473798B (zh) 2015-02-21
PT2318390E (pt) 2013-07-10
EP2318390A1 (en) 2011-05-11
MY152008A (en) 2014-08-15
GEP20135786B (en) 2013-03-11
CR20110169A (es) 2011-05-16
JO2871B1 (en) 2015-03-15
ECSP11010912A (es) 2011-04-29
US20140031393A1 (en) 2014-01-30
AU2009284867A2 (en) 2011-04-21
US8592597B2 (en) 2013-11-26
DK2318390T3 (da) 2013-07-08
TW201010993A (en) 2010-03-16
PE20110300A1 (es) 2011-06-16
AU2009284867A1 (en) 2010-03-04
EA201170384A1 (ru) 2011-10-31
BRPI0917705A2 (pt) 2016-02-16
HRP20130653T1 (en) 2013-08-31
CO6321166A2 (es) 2011-09-20
AU2009284867B2 (en) 2014-08-28
CY1114452T1 (el) 2016-10-05
PE20141174A1 (es) 2014-09-19
EP2318390B1 (en) 2013-05-01
US20110172275A1 (en) 2011-07-14
HK1157756A1 (en) 2012-07-06
SMT201300085B (it) 2013-09-06
PL2318390T3 (pl) 2013-09-30
WO2010024451A1 (en) 2010-03-04
DOP2011000061A (es) 2011-04-15
RS52872B (en) 2013-12-31
US8969387B2 (en) 2015-03-03
CN102197033A (zh) 2011-09-21
KR101629181B1 (ko) 2016-06-13

Similar Documents

Publication Publication Date Title
UY32074A (es) Compuestos de pirrol
UY32481A (es) Derivados de benzofurano
EA201290800A1 (ru) Гетероциклическое соединение
BRPI0520870B8 (pt) compostos intermediários para a preparação de alfa-mercaptoacetanilidas de s-triazolila
ATE542798T1 (de) Organische verbindungen
CY1112705T1 (el) Συντηγμενες κυκλικες ενωσεις
UY32142A (es) Preparación de una quinoliniloxidifenilciclopropanodicarboxamida
BR112012033350A2 (pt) "composição e métodos para modular a via de sinalização de wnt"
ES2571483T3 (es) Producto intermedio para producir un éster de ácido sulfónico cíclico
EA201590979A1 (ru) Способы и промежуточные химические соединения для получения фармацевтических средств
RS53003B (en) C7-FLUORO SUBSTITUTED TETRACYCLINE UNITS
RS52255B (en) NALMEFEN HYDROCHLORIDE DIHYDRATE
UY31688A1 (es) Plaguicidas
CY1112829T1 (el) Νεα μεθοδος συνθεσης για την αγομελατινη
BR122018074319B8 (pt) Método para preparar um composto de fórmula 14
BRPI0821102A2 (pt) Preparação de derivados de di-hidropirrol como intermediários
DK2190426T3 (da) Griseofulvin-analoger til behandling af cancer ved hæmning af centrosomal clusterdannelse
MA32296B1 (fr) Derives de piperidine 3,4-substitues comme inhibiteurs de la renine
DK2197860T3 (da) Nye forbindelser som adenosin-A1-receptorantagonister
GT200700074A (es) Fungicidas
HK1168102A1 (en) Process for the preparation of a compound useful as an inhibitor of tafia
CR20110111A (es) Composicion farmaceutica solida
BR112015009988A2 (pt) melhoramentos em compostos orgânicos ou relativos
CY1111573T1 (el) Νεα μεθοδος συνθεσης της αγομελατινης
DOP2011000296A (es) Compuesto de pirazol

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20181113